129 related articles for article (PubMed ID: 1670502)
1. The synthesis, stability and biological activity of bis-intercalating bis-daunomycin hydrazones.
Phillips DR; Baguley BC; Brownlee RT; Cacioli P; Chandler CJ; Kyratzis I; Reiss JA; Scourides PA
Drug Des Deliv; 1990 Mar; 5(3):203-19. PubMed ID: 1670502
[TBL] [Abstract][Full Text] [Related]
2. Bis-daunomycin hydrazones: interactions with DNA.
Phillips DR; Brownlee RT; Reiss JA; Scourides PA
Invest New Drugs; 1992 Jul; 10(2):79-88. PubMed ID: 1500269
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of mono- and bis-hydrazones of cyclic aminoguanidines.
Sidzhakova D; Panajotova B; Mardirossjan Z; Tabakova S; Maneva L; Marinova V; Golovinsky E
Pharmazie; 1993 Jun; 48(6):417-9. PubMed ID: 8341729
[No Abstract] [Full Text] [Related]
4. Synthesis of 9,10-anthraquinone monoalkylaminoalkylhydrazones as potential antitumor drugs.
Antonini I; Polucci P; Cola D; Palmieri G; Martelli S; Bontemps-Gracz M
Farmaco; 1993 Dec; 48(12):1641-8. PubMed ID: 8135988
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of polyamine-linked bis-daunomycin hydrazones and their interaction with DNA.
Hook RJ; Phillips DR; Reiss JA
Anticancer Drug Des; 1989 Oct; 4(3):173-90. PubMed ID: 2803466
[TBL] [Abstract][Full Text] [Related]
6. In vitro antitumor activity of fused 2-carboxaldehyde N,N-dimethylhydrazone-3-methylfuran derivatives.
Carneiro do Nascimento S; Nebois P; Benameur L; Boitard M; Bartoli MH; Fillion H
Pharmazie; 1994 Apr; 49(4):296-7. PubMed ID: 8197234
[No Abstract] [Full Text] [Related]
7. Bis-naphthylureas and related compounds: synthesis, chemical properties, DNA affinity and antineoplastic activity.
Bruno AM; Asis SE; Gaozza CH
Pharmazie; 2001 May; 56(5):361-5. PubMed ID: 11400549
[TBL] [Abstract][Full Text] [Related]
8. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
[TBL] [Abstract][Full Text] [Related]
9. Azinyl and diazinyl hydrazones derived from aryl N-heteroaryl ketones: synthesis and antiproliferative activity.
Easmon J; Heinisch G; Pürstinger G; Langer T; Osterreicher JK; Grunicke HH; Hofmann J
J Med Chem; 1997 Dec; 40(26):4420-5. PubMed ID: 9435912
[TBL] [Abstract][Full Text] [Related]
10. The DNA-association and biological activity of a new bis(14-thiadaunomycin).
Skorobogaty A; Brownlee RT; Chandler CJ; Kyratzis I; Phillips DR; Reiss JA; Trist H
Anticancer Drug Des; 1988 Jun; 3(1):41-56. PubMed ID: 3382506
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic evaluation of some carbohydrazones and thiocarbohydrazones of various unsaturated ketones and related Mannich bases.
Dimmock JR; Kumar P; Allen TM; Kao GY; Halleran S; Balzarini J; de Clercq E
Pharmazie; 1997 Mar; 52(3):182-6. PubMed ID: 9109166
[TBL] [Abstract][Full Text] [Related]
12. Chelating agents as potential antitumorals: alpha-(N)-heterocyclic hydrazones and bis-alpha-(N)-heterocyclic hydrazones.
Savini L; Massarelli P; Chiasserini L; Nencini C; Pellerano C
Farmaco; 1997 Oct; 52(10):609-13. PubMed ID: 9507672
[TBL] [Abstract][Full Text] [Related]
13. Novel antitumor agent family of 1H-benzo[c,d]indol-2-one with flexible basic side chains: synthesis and biological evaluation.
Yin H; Xu Y; Qian X
Bioorg Med Chem; 2007 Feb; 15(3):1356-62. PubMed ID: 17129733
[TBL] [Abstract][Full Text] [Related]
14. [14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
Povarov LS; Leont'eva OV; Bernaki PD; Olsuf'eva EN; Salimova EI; Pera P; Preobrazhenskaia MN
Bioorg Khim; 1995 Dec; 21(12):925-32. PubMed ID: 8602889
[TBL] [Abstract][Full Text] [Related]
15. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
16. 1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
Antonini I; Polucci P; Jenkins TC; Kelland LR; Menta E; Pescalli N; Stefanska B; Mazerski J; Martelli S
J Med Chem; 1997 Nov; 40(23):3749-55. PubMed ID: 9371240
[TBL] [Abstract][Full Text] [Related]
17. Bis-naphthalimides: a new class of antitumor agents.
Braña MF; Castellano JM; Morán M; Pérez de Vega MJ; Romerdahl CR; Qian XD; Bousquet P; Emling F; Schlick E; Keilhauer G
Anticancer Drug Des; 1993 Aug; 8(4):257-68. PubMed ID: 8240655
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of a new bisintercalating anthracycline antibiotic.
Chaires JB; Leng F; Przewloka T; Fokt I; Ling YH; Perez-Soler R; Priebe W
J Med Chem; 1997 Jan; 40(3):261-6. PubMed ID: 9022792
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel ribavirin hydrazone derivatives and anti-proliferative activity against A549 lung cancer cells.
Liu WY; Li HY; Zhao BX; Shin DS; Lian S; Miao JY
Carbohydr Res; 2009 Jul; 344(11):1270-5. PubMed ID: 19527904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
